Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

11.04USD
26 Feb 2015
Change (% chg)

$0.20 (+1.85%)
Prev Close
$10.84
Open
$10.80
Day's High
$11.08
Day's Low
$10.49
Volume
175,297
Avg. Vol
231,289
52-wk High
$19.25
52-wk Low
$8.34

VNDA.OQ

Chart for VNDA.OQ

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders. The Company’s product portfolio includes: HETLIOZ (tasimelteon), a product for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24); Fanapt (iloperidon... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $429.82
Shares Outstanding(Mil.): 39.65
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): 35.50 175.65 40.21
EPS (TTM): 0.31 -- --
ROI: 14.71 -2.69 16.34
ROE: 19.70 -4.48 17.27
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks